NDC 10544-020

Cephalexin

Cephalexin

Cephalexin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Blenheim Pharmacal, Inc.. The primary component is Cephalexin.

Product ID10544-020_9fc0b42f-ecb7-4070-a18c-e57d5a53778a
NDC10544-020
Product TypeHuman Prescription Drug
Proprietary NameCephalexin
Generic NameCephalexin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2010-09-28
Marketing CategoryANDA / ANDA
Application NumberANDA062702
Labeler NameBlenheim Pharmacal, Inc.
Substance NameCEPHALEXIN
Active Ingredient Strength500 mg/1
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 10544-020-10

10 CAPSULE in 1 BOTTLE (10544-020-10)
Marketing Start Date2010-09-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10544-020-20 [10544002020]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062702
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-09-28
Inactivation Date2019-10-29

NDC 10544-020-28 [10544002028]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062702
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-09-28
Inactivation Date2019-10-29

NDC 10544-020-10 [10544002010]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062702
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-09-28
Inactivation Date2019-10-29

NDC 10544-020-30 [10544002030]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062702
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-09-28
Inactivation Date2019-10-29

NDC 10544-020-40 [10544002040]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062702
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-09-28
Inactivation Date2019-10-29

NDC 10544-020-14 [10544002014]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA062702
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-09-28
Inactivation Date2019-10-29

Drug Details

Active Ingredients

IngredientStrength
CEPHALEXIN500 mg/1

OpenFDA Data

SPL SET ID:12b6bac5-00a3-437b-a172-d4e09c273c8c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309114
  • UPC Code
  • 0310544020106
  • NDC Crossover Matching brand name "Cephalexin" or generic name "Cephalexin"

    NDCBrand NameGeneric Name
    0093-2238CephalexinCephalexin
    0093-2240CephalexinCephalexin
    0093-3145CephalexinCephalexin
    0093-3147CephalexinCephalexin
    0093-4175CephalexinCephalexin
    0093-4177CephalexinCephalexin
    0143-9769CephalexinCephalexin
    0143-9770CephalexinCephalexin
    0143-9897CephalexinCephalexin
    0143-9898CephalexinCephalexin
    67877-220CephalexinCephalexin
    67877-254CephalexinCephalexin
    67877-255CephalexinCephalexin
    67877-219CephalexinCephalexin
    68071-1585CephalexinCephalexin
    68071-4177CephalexinCephalexin
    68071-3186CephalexinCephalexin
    68071-4355CephalexinCephalexin
    68071-4342CephalexinCephalexin
    68071-4465CephalexinCephalexin
    68071-4233CephalexinCephalexin
    68071-4406CephalexinCephalexin
    68071-4429CephalexinCephalexin
    68071-4587CephalexinCephalexin
    68071-4516CephalexinCephalexin
    68071-4434CephalexinCephalexin
    0440-1243CephalexinCephalexin
    0440-7244CephalexinCephalexin
    68180-124cephalexincephalexin
    68180-441cephalexincephalexin
    68180-121CephalexinCephalexin
    68180-123cephalexincephalexin
    68180-440cephalexincephalexin
    68180-122CephalexinCephalexin
    68788-8986CephalexinCephalexin
    68788-9404CephalexinCephalexin
    68788-7271CephalexinCephalexin
    68788-9713CephalexinCephalexin
    68788-9326CephalexinCephalexin
    68788-9951cephalexincephalexin
    68788-8994CephalexinCephalexin
    68788-7391CephalexinCephalexin
    68788-9539CephalexinCephalexin
    68788-9950cephalexincephalexin
    68788-9956cephalexincephalexin
    68788-9538CephalexinCephalexin
    68788-9752cephalexincephalexin
    68788-9957cephalexincephalexin
    69543-102CephalexinCephalexin
    69778-930CephalexinCephalexin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.